Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia

PubMed: 25186086

Comparative 10-Years Prognosis of Fibrotest (FT) and Liver Stiffness Measurement (LSM) by Transient Elastog-raphy (TE, Fibroscan) in 9364 Chronic Liver Diseases (CLD) Patients (Pts)